PIDOTIMOD A NEW EFFICIENT PRODUCT IN IMMUNOLOGICAL PROPHYLAXIS AND IMMUNOLOGICAL THERAPY OF RESPIRATORY INFECTIONS IN CHILDREN

Abstract

The article contains analysis of results of international trial of pidotimod (imunorix) efficiency. pidotimod is a new safe immunomodulator, which is both efficient in prophylactic use and as a medication. At the same time, the drug is capable of intensify the effect of antibiotics and other medications. This fact is confirmed by the results of controlled trials with participation of a large number of patients. pidotimod is ministerial to a faster disappearance of signs and symptoms of infection, anticipating the recovery with reduced administration of associated drugs.Key words: pidotimod, immunomodulator, acute respiratory infections, prophylaxis, treatment.